CIM-212930

N/A

Report date: 2025/01/26 18:27:38
NME

Base Information

Drug NameCIM-212930
Drug Alias NameCIM-212930
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium/bile acid cotransporter inhibitors
TargetsSodium/bile acid cotransporter
Therapy Area/IndicationsCholestasisHepatitis B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumNetherlands
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesKu Leuven
China Registration ClassN/A

Develop Information

Active CompaniesUniversitaet GentAcademic Medical Center University of AmsterdamCenter for Innovation and Stimulation of Drug Discovery +[5] 
Inactive CompaniesN/A
Active IndicationsCholestasisHepatitis B
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A